Andere talen Cartesian Therapeutics, Inc.

Aandelen

RNAC

US8162123025

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 07-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
36,58 ^USD	+5,42%		+5,36%	+76,87%

04/06	CARTESIAN THERAPEUTICS, INC. : Oppenheimer bevestigt koopadvies	ZM
24/05	CARTESIAN THERAPEUTICS, INC. : Mizuho Securities herhaalt koopadvies	ZM

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Cartesian Therapeutics Announces New Employment Inducement Grant	06/06
Cartesian Gets Regenerative Medicine Advanced Therapy Label for Myasthenia Gravis Drug Candidate	22/05
Cartesian Therapeutics, Inc. Receives FDA Regenerative Medicine Advanced Therapy Designation for Descartes-08 for the Treatment of Myasthenia Gravis	22/05
Cartesian Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Descartes-08 for the Treatment of Myasthenia Gravis	22/05
Cartesian Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ	13/05
Cartesian Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update	08/05
Cartesian Therapeutics Announces New Employment Inducement Grants	06/05
Cartesian Therapeutics to Present at the ASGCT 27th Annual Meeting	22/04
Cartesian Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference	04/04
Cartesian Therapeutics Announces New Employment Inducement Grants	04/04
Cartesian Therapeutics Announces Approval of Conversion of Series A Convertible Preferred Stock and Plans to Effect Reverse Stock Split	28/03
Cartesian Therapeutics : Termination of Material Agreement - Form 8-K	14/03
Cartesian Therapeutics, Inc Receives Notice from Audentes Therapeutics, Inc of Astellas? Termination of the License and Development Agreement	14/03
Cartesian Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	07/03
Cartesian Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update	07/03
Cartesian Therapeutics to Participate in Upcoming Investor Conferences	06/03
Cartesian Therapeutics Announces New Employment Inducement Grant	05/03
Cartesian Therapeutics, Inc. Announces Resignation of Aymeric Sallin as Member of the Board of Director and Member of Compensation Committee	05/03
Cartesian Therapeutics Establishes New Corporate Headquarters and State-of-the-Art mRNA Cell Therapy cGMP Manufacturing Facility in Frederick, Maryland	05/03
Cartesian Therapeutics, Inc. Establishes New Corporate Headquarters and mRNA Cell Therapy cGMP Manufacturing Facility in Frederick, Maryland	05/03

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Cartesian Therapeutics, Inc.

Aandelen

RNAC

US8162123025

Andere talen

Filters